Amylose AL - ARS Limousin
Amylose AL - ARS Limousin
Amylose AL - ARS Limousin
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Principales publications<br />
www.cr.amylose-al.fr<br />
Publications 2012<br />
•Royer B, Merlusca L, Abraham J, Musset L, Haroche J, Choquet S, Leleu X, Sebban C, Decaux O, Galicier L, Roussel M, Recher<br />
C, Banos A, Guichard I, Brisseau JM, Godmer P, Hermine O, Deplanque G, Facon T, Asli B, Leblond V, Fermand JP, Marolleau<br />
JP, Jaccard A. Efficacy of lenalidomide in POEMS syndrome: A retrospective study of 20 patients. Am J Hematol. 2012 Dec<br />
10.<br />
•Leung N, Bridoux F, Hutchison CA, Nasr SH, Cockwell P, Fermand JP, Dispenzieri A, Song KW, KyleRA.Monoclonal gammopathy<br />
of renal significance (MGRS): when MGUS is no longer undetermined or insignificant. Blood. 2012 Oct 9<br />
•El Hamel C, Aldigier JC, Oblet C, Laffleur B, Bridoux F, Cogné M. Specific impairment of proximal tubular cell proliferation by<br />
a monoclonal κ light chain responsible for Fanconi syndrome. Nephrol Dial Transplant. 2012 Sep 28<br />
•Moumas E, Bridoux F, Leroy F, Belmouaz S, Randriamalala E, Desport E, Dreyfus B, Delbès S, Quellard N, Touchard G.<br />
•Fanconi syndrome and chronic kidney disease in paroxysmal nocturnal hemoglobinuria: effect of eculizumab therapy. Clin<br />
Nephrol. 2012 Oct;78(4):316-21.<br />
•Desport E, Bridoux F, Sirac C, Delbes S, Bender S, Fernandez B, Quellard N, Lacombe C, Goujon JM, Lavergne D, Abraham<br />
J, Touchard G, Fermand JP, Jaccard A. <strong>AL</strong> Amyloidosis. Orphanet J Rare Dis. 2012 Aug 21;7(1):54.<br />
•Valleix S, Gillmore JD, Bridoux F, Mangione PP, Dogan A, Nedelec B, Boimard M, Touchard G, Goujon JM, Lacombe C, Lozeron<br />
P, Adams D, Lacroix C, Maisonobe T, Planté-Bordeneuve V, Vrana JA, Theis JD, Giorgetti S, Porcari R, Ricagno S, Bolognesi M,<br />
Stoppini M, Delpech M, Pepys MB, Hawkins PN, Bellotti V. Hereditary systemic amyloidosis due to Asp76Asn variant β2-<br />
microglobulin. N Engl J Med. 2012 Jun 14;366(24):2276-83.<br />
•Palladini G, Dispenzieri A, Gertz MA, Kumar S, Wechalekar A, Hawkins PN, Schönland S, Hegenbart U, Comenzo R, Kastritis E,<br />
Dimopoulos MA, Jaccard A, Klersy C, Merlini G. New criteria for response to treatment in immunoglobulin light chain<br />
amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes. J Clin Oncol. 2012 Dec<br />
20;30(36):4541-9<br />
•Mekinian A, Jaccard A, Soussan M, Launay D, Berthier S, Federici L, Lefèvre G, Valeyre D, Dhote R, Fain O; Centre de<br />
Référence des <strong>Amylose</strong>s immunoglobulinémiques et autres maladies liées aux dépots des immunoglobulines monoclonales. 18F-<br />
FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review. Amyloid. 2012 Jun;19(2):94-8.<br />
•Bridoux F, Delbes S, Sirac C, Pourreau F, Puyade M, Desport E, Jaccard A, Fermand JP, Touchard. Renal disorders associated<br />
with monoclonal gammopathies: diagnostic and therapeutic progress G. Presse Med. 2012 Mar;41(3 Pt 1):276-89.<br />
31
Change language